|Articles|December 8, 2011
Video blog: BOLERO-2 and Afinitor in breast cancer
Author(s)Debu Tripathy
Advertisement
Dr. Debu Tripathy explains the updated results of the BOLERO-2 study, which looked at Afinitor (everolimus) and an aromatase inhibitor in metastatic breast cancer. How useful will this new drug be in metastatic breast cancer?
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on CURE
1
Top 5 Breast Cancer Stories of 2025: Research, Treatments and Care
2
Tukysa Makes Waves as Firstline Maintenance in HER2+ Breast Cancer
3
FDA Grants Breakthrough Status to Zoldonrasib in Lung Cancer
4
Breaking Down Side Effects of Tukysa in HER2+ Breast Cancer
5